THE OPERA TRIAL: Fish Oil and Postoperative Atrial Fibrillation: The Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation Randomized Trial”

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

Pablo Avanzas

Effect of Loading Dose of Atorvastatin Prior to Planned PCI: The SECURE-PCI Randomized Clinical Trial

Alberto J. Lorenzatti

A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest

Pablo Avanzas

Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE Trial)

Pablo Avanzas

Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients (CAMELLIA–TIMI 61)

Amelia Carro

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness (MARINER)

Pablo del Castillo Vazquez,  Antoni Martínez-Rubio

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis: the PIVOTAL trial

Sang Hong Baek

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia: The REDUCE-IT trial

Andréa Araujo Brandao

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

Ricardo Lopez Santi

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (DAPA-HF) Study

Koji Hasegawa

Polypill as a Strategy for Primary and Secondary Cardiovascular Prevention

Edgardo Escobar

SGLT2 Inhibitors Reduce Blood Pressure and Left Ventricular Mass

Thomas Kahan

Long-Term Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54

Pablo Avanzas